Can CVS Health (CVS) Still Look Cheap After A 50% Run?

September 12, 2026 - 11:33

CVS Health has posted a 49.8% gain over the past three years, a run that might normally suggest the stock has become fully valued. Yet a closer look at the numbers shows the company still trades at levels that many investors consider cheap on broad measures.

The share price increase indicates that the market has already given credit for progress in the business. The central question now is how much room remains for further gains. Recent bullish commentary from analysts has pointed to a recovery at Aetna and the possibility that share buybacks could return. Those factors have helped support the positive view on the stock.

Even after the strong performance, valuation checks do not show a stock that has become expensive. Instead, the shares continue to look inexpensive relative to earnings and other common metrics. That gap between price performance and valuation has kept the stock on the radar for investors who focus on value.

The debate is whether the market is underestimating the durability of the company's earnings power. If Aetna continues to improve and buybacks resume, the case for additional upside could strengthen. For now, the stock sits in an unusual spot: a strong multiyear winner that still screens as a value play.